Blog

January 5, 2022 5 Changes to be Implemented by DEA
December 16, 2021 Letter from the CEO on 2022
December 2, 2021 NCDQS 2021 Recap
November 18, 2021 Top SOM Insights from 2021
October 25, 2021 How to Lessen the Financial Burden of PBM Pharmacy Audits
October 21, 2021 Balancing Disruption with Regulation: Ravkoo, DTP & Marketplaces
October 21, 2021 NABP DDA: New Process & “Ineligibility Matrix”
October 6, 2021 Imminent Approval of Psilocybin
October 6, 2021 The Increasing Trend of Drug Price Transparency
September 28, 2021 Top 5 Mistakes Pharmacies Make During URAC Accreditation
September 23, 2021 MDMA in Phase 3 Trials for FDA Approval
September 8, 2021 Cash-Pay Ketamine Treatment Programs Explode in Popularity and Access

  • (800) 962-8760
  • hello@pharma.solutions
  • 705 Montgomery Avenue, Suite 200
    Penn Valley, PA 19072

Quick Links

Support

Newsletter Signup

Subscribe

2022 All rights reserved by Pharma Solutions USA, Inc.